FDA Approved Drugs for Rare Diseases and Disorders

Drugs Approved in 2019

Otezla (apremilast); Celgene; For the treatment of adults with oral ulcers associated with Behçet’s Disease, Approved July 2019

Drugs Approved in 2009

Cervarix [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant; GlaxoSmithKline; For the prevention of cervical cancer and cervical intraepithelial neoplasia caused by HPV types 16 and 18, Approved October 2009

Drugs Approved in 1997

Carbatrol; Elan Pharmaceuticals; Treatment for epileptic seizures and trigeminal neuralgia, Approved September 1997